|
Nashville, Tennessee, (November 3, 2003) - Renal Care Group, Inc. (NYSE:RCI)
today announced that it has appointed David M. Dill as executive vice
president and chief financial officer. Mr. Dill succeeds R. Dirk Allison,
who has resigned to pursue another opportunity in the healthcare industry.
Mr. Allison will remain with the Company through November 30, 2003 to
assist in a smooth transition. Mr. Dill joined Renal Care Group shortly
after the Company’s initial public offering in 1996 and, immediately
prior to this appointment, served as senior vice president, finance,
responsible for consolidated accounting, financial reporting, corporate
budgeting and strategic planning.
William P. Johnston, the Company's chairman of the board, commented, “Dirk
Allison provided crucial services to Renal Care Group during his four-year
tenure and has played an important role in the continuing financial success
of the Company. On behalf of the Board of Directors, associates and management
team, I wish him the very best in his new endeavors and thank him for
his many contributions to Renal Care Group.”
Gary Brukardt, the Company’s president and chief executive officer,
said, “This is a well-deserved promotion for David Dill, and we
are pleased that David has assumed this leadership role with the Company.
While we will miss Dirk Allison, we are fortunate to have a capable successor
in David, who has consistently demonstrated a thorough understanding
of the Company's strategic focus, business and finances. David knows
our shareholders, employees and other stakeholders and is well acquainted
with the investment community. I have every confidence in his ability
to play a key role in Renal Care Group's mission of providing optimal
care for our patients, while delivering outstanding results for our shareholders.”
Mr. Allison said, “It is difficult for me to leave Renal Care
Group given my respect for my colleagues and the many lasting friendships
I have formed. Having worked closely with David Dill for four years,
I believe Renal Care Group will continue to grow and succeed under his
leadership as CFO working closely with the other members of Renal Care
Group's outstanding management team.”
Prior to joining Renal Care Group in June 1996, Mr. Dill, 35, was an
accountant with Deloitte & Touche LLP. Mr. Dill holds a Bachelor
of Science degree in accounting from Murray State University and is a
certified public accountant.
Renal Care Group is a specialized dialysis services company that provides
care to patients with kidney disease. The Company treats over 21,300
patients at more than 270 owned outpatient dialysis facilities, in addition
to providing acute dialysis services at more than 120 hospitals. Over
6,500 associates provide services across the Company’s 27-state
network. More information about Renal Care Group, Inc. can be found at
www.renalcaregroup.com.
Certain statements in this press release, particularly those of Mr.
Johnston, Mr. Brukardt and Mr. Allison, constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements, which are usually
preceded by words like expect, plan, intend, will and the like, include
statements regarding our future performance and any other statements
that necessarily depend on future events. These forward-looking statements
reflect management’s expectations and are based upon currently
available information. These forward-looking statements involve known
and unknown risks, uncertainties and other factors that may cause actual
results, performance or achievements of Renal Care Group to differ materially
from those expressed in or implied by the forward-looking statements,
including risks related to: dependence on executive officers; changes
in the Medicare and Medicaid programs; payment reductions by private
insurers, hospitals or managed care organizations; changes in the health
care delivery, financing or reimbursement systems; risks related to the
drug Epogen (EPO); compliance with health care and other applicable laws;
and the integration of acquired companies. These and other factors affecting
the Company are discussed in more detail in Renal Care Group’s
reports filed with the Securities and Exchange Commission, including
without limitation Renal Care Group’s most recent annual report
on Form 10-K and any quarterly reports on Form 10-Q filed after that
annual report. Copies of these filings are available from Renal Care
Group upon request.
Contact:
Renal Care Group Inc., Nashville
Terry Proveaux, 615-345-5577
|
Press Releases